Results 51 to 60 of about 68,959 (168)

Peritoneovenous shunt for palliation of malignant ascites [PDF]

open access: yesCancer, 1982
Forty patients with malignant ascites refractory to conventional medical management had peritoneovenous shunt for palliation. The shunt provided effective palliation in 28 with decrease in weight, abdominal girth, number of paracenteses required and increase in urine output.
R, Qazi, E D, Savlov
openaire   +2 more sources

Peritoneovenous shunting is an effective treatment for intractable ascites.

open access: yes, 2005
AIM AND METHODS: A retrospective review was carried out of children undergoing peritoneovenous shunting for intractable ascites. RESULTS: 11 children, aged 3 months to 12 years (median 31 months) underwent peritoneovenous shunting over the past 17 years.
E M Kiely   +4 more
core   +1 more source

Parent’s involvement in decisions when their child is admitted to hospital with suspected shunt malfunction: study protocol [PDF]

open access: yes, 2009
Aim.  This paper outlines the protocol for a study aimed at exploring parent’s involvement during professional–parent interactions and decisions about their child’s care in the context of suspected shunt malfunction. Background.
Smith, Joanna   +7 more
core   +1 more source

Drainage of malignant ascites: patient selection and perspectives

open access: yesCancer Management and Research, 2017
Maciej Stukan Department of Gynecologic Oncology, Gdynia Oncology Center, Szpitale Wojewodzkie w Gdyni Sp. z o.o., Gdynia, Poland Abstract: Malignant ascites (MA) is a sign of advanced cancer and poor prognosis.
Stukan M
doaj  

Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998

open access: yes, 2000
Background/Aims: This is the review of our experience in the treatment of malignant ascites using Le Veen and Denver peritoneovenous shunt. Methodology: From 1975-1998, 24 peritoneovenous shunts were inserted in 22 patients with malignant ascites ...
Tueche, Serge Gabin, Pector, Jean Claude
core  

Repositioning of Surgically Placed Peritoneovenous Shunt Catheter by Forming “In Situ” Loop Snare

open access: yes, 2011
We describe a technique that allows repositioning of malfunctioning peritoneovenous shunt (PVS) catheters. We report a 67-year-old female with refractory ascites, who presented with malfunctioning PVS. The catheter tip was outside the superior vena cava
Souheil Saddekni   +4 more
core   +1 more source

The effects on arterial haemoglobin oxygen saturation and on shunt of increasing cardiac output with dopamine or dobutamine during one-lung ventilation [PDF]

open access: yes, 2004
Publisher's copy made available with the permission of the publisher © Australian Society of AnaesthetistsTheoretically, if the cardiac output were increased in the presence of a given intrapulmonary shunt, the arterial saturation should improve as the ...
Russell, W.   +3 more
core   +1 more source

Refractory Ascites: Treatment and Complications Utilizing Peritoneovenous (Denver) Shunt

open access: yes, 2017
Intractable ascites has long been an antagonizing problem for patients and medical providers. It is debilitating and frequently cannot be prevented by standard medical therapy.
Parvaneh Shadkam-Farrokhi, Edward Lee
core   +1 more source

Chylous ascites in cirrhosis: a case report and review of the literature

open access: yes, 1989
Chylous ascites is an uncommon clinical entity which results from the accumulation of fat, predominantly chylomicrons, in the ascitic fluid. Conventional treatment methods are unsatisfactory.
Ward, Michael   +9 more
core   +1 more source

Peritoneovenous shunt in treatment of ascites in patients with cirrhosis. A preliminary report with special reference to pathophysiology

open access: yes, 1983
Udgivelsesdato: 1983-MayPeritoneovenous shunts (LeVeen type) were implanted in seven patients with cirrhosis complicated by ascites refractory to diuretic treatment. Three patients died of gastrointestinal bleeding and hepatic coma 1 to 7 weeks after the
Staehr-Johansen, T   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy